Diabetes is classified as an impairment of the body's ability to control blood glucose
levels. Uncontrolled hyperglycemia can give rise to macrovascular (i.e., heart disease and
stroke) and microvasculature damage such as retinopathy, nephropathy and neuropathy. These
comorbidities may definitively reduce quality of life.
Hypotheses to be tested:
1. The ingestion of amino acids L-Isoleucine and L-Leucine at a therapeutic dose prior to a
glucose load will concurrently and independently improve glucose tolerance.
2. The ingestion of L-Isoleucine and L-Leucine separately or together will have a minimal
effect on incretin responses of Glucagon-like peptide-1 and Glucose-dependent
insulinotropic peptide (GLP-1, GIP).